RPAM
Rhenman & Partners Asset Management’s Immunocore IMCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $887K | Hold |
28,278
| – | – | 0.11% | 88 |
|
|
2025
Q1 | $839K | Sell |
28,278
-30,000
| -51% | -$890K | 0.1% | 88 |
|
|
2024
Q4 | $1.72M | Hold |
58,278
| – | – | 0.18% | 83 |
|
|
2024
Q3 | $1.81M | Hold |
58,278
| – | – | 0.15% | 87 |
|
|
2024
Q2 | $1.98M | Sell |
58,278
-21,500
| -27% | -$729K | 0.19% | 77 |
|
|
2024
Q1 | $5.19M | Sell |
79,778
-4,500
| -5% | -$293K | 0.49% | 53 |
|
|
2023
Q4 | $5.76M | Sell |
84,278
-5,000
| -6% | -$342K | 0.58% | 56 |
|
|
2023
Q3 | $4.63M | Hold |
89,278
| – | – | 0.5% | 51 |
|
|
2023
Q2 | $5.35M | Sell |
89,278
-42,010
| -32% | -$2.52M | 0.56% | 55 |
|
|
2023
Q1 | $6.24M | Sell |
131,288
-18,712
| -12% | -$889K | 0.68% | 49 |
|
|
2022
Q4 | $8.56M | Hold |
150,000
| – | – | 0.89% | 41 |
|
|
2022
Q3 | $8.57M | Buy |
150,000
+10,000
| +7% | +$571K | 0.9% | 44 |
|
|
2022
Q2 | $5.22M | Sell |
140,000
-30,472
| -18% | -$1.14M | 0.59% | 52 |
|
|
2022
Q1 | $5.1M | Buy |
170,472
+80,472
| +89% | +$2.41M | 0.5% | 61 |
|
|
2021
Q4 | $3.07M | Hold |
90,000
| – | – | 0.2% | 83 |
|
|
2021
Q3 | $3.34M | Hold |
90,000
| – | – | 0.23% | 84 |
|
|
2021
Q2 | $3.52M | Buy |
+90,000
| New | +$3.52M | 0.24% | 85 |
|